- Home
- BSX vs UBS Comparison
BSX vs UBS Comparison
Compare BSX & UBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSX
- UBS
- Stock Information
- Founded
- BSX 1979
- UBS 1862
- Country
- BSX United States
- UBS Switzerland
- Employees
- BSX N/A
- UBS N/A
- Industry
- BSX Medical/Dental Instruments
- UBS Major Banks
- Sector
- BSX Health Care
- UBS Finance
- Exchange
- BSX Nasdaq
- UBS Nasdaq
- Market Cap
- BSX 120.7B
- UBS 96.1B
- IPO Year
- BSX 1992
- UBS N/A
- Fundamental
- Price
- BSX $81.60
- UBS $28.54
- Analyst Decision
- BSX Strong Buy
- UBS Buy
- Analyst Count
- BSX 21
- UBS 4
- Target Price
- BSX $85.24
- UBS $32.18
- AVG Volume (30 Days)
- BSX 4.2M
- UBS 1.9M
- Earning Date
- BSX 10-24-2024
- UBS 08-14-2024
- Dividend Yield
- BSX N/A
- UBS 3.67%
- EPS Growth
- BSX 104.77
- UBS N/A
- EPS
- BSX 1.23
- UBS 0.71
- Revenue
- BSX $15,229,000,000.00
- UBS $46,439,000,000.00
- Revenue This Year
- BSX $15.45
- UBS N/A
- Revenue Next Year
- BSX $10.88
- UBS $0.31
- P/E Ratio
- BSX $66.48
- UBS $38.84
- Revenue Growth
- BSX 13.65
- UBS 38.37
- 52 Week Low
- BSX $48.35
- UBS $23.23
- 52 Week High
- BSX $82.47
- UBS $32.13
- Technical
- Relative Strength Index (RSI)
- BSX 66.25
- UBS 33.57
- Support Level
- BSX $80.50
- UBS $30.39
- Resistance Level
- BSX $82.47
- UBS $31.46
- Average True Range (ATR)
- BSX 1.12
- UBS 0.36
- MACD
- BSX 0.25
- UBS -0.21
- Stochastic Oscillator
- BSX 81.79
- UBS 0.17
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
About UBS UBS Group AG Registered
The core of UBS is its global wealth management business focusing on high and ultra-high-net-worth individuals. UBS is also a conventional retail and commercial bank in its Swiss home market. Its investment bank and asset management businesses support its wealth management operations, but also leverage its strength in wealth management to serve third-party clients.